Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals.

Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals.

Item

http://www.wikidata.org/entity/Q30414047

Q30414047

about

Genetic susceptibility to cerebrovascular disease Impact of Genotype on EPA and DHA Status and Responsiveness to Increased Intakes Computationally Modeling Lipid Metabolism and Aging: A Mini-review Early Detection System of Vascular Disease and Its Application Prospect The potential applications of Apolipoprotein E in personalized medicine Human plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphism Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: the HALCyon programme.Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease?Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma.Apolipoprotein E gene polymorphism and risk for coronary heart disease in the Chinese population: a meta-analysis of 61 studies including 6634 cases and 6393 controls.Association of TOMM40 and SLC22A4 polymorphisms with ischemic stroke.APOE ε4 and lipid levels affect risk of recurrent nonlobar intracerebral hemorrhage.Common low-density lipoprotein receptor p.G116S variant has a large effect on plasma low-density lipoprotein cholesterol in circumpolar inuit populations.Relation between Apolipoprotein E Gene Polymorphism and Severity of Coronary Artery Disease in Acute Myocardial Infarction Association between APOE polymorphism and metabolic syndrome in Uyghur ethnic men.Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.Interactive effects of C-reactive protein levels on the association between APOE variants and triglyceride levels in a Taiwanese population Selecting instruments for Mendelian randomization in the wake of genome-wide association studies.Apolipoprotein E polymorphism and colorectal neoplasm: results from a meta-analysis.APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome Management of acute ischaemic stroke in patients with dementia.APOE gene and neuropsychiatric disorders and endophenotypes: A comprehensive review.Protective role of the apolipoprotein E2 allele in age-related disease traits and survival: evidence from the Long Life Family Study.Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.Apolipoprotein E genotype status affects habitual human blood mononuclear cell gene expression and its response to fish oil intervention.Molecular assessment of some cardiovascular genetic risk factors among Iraqi patients with ischemic heart diseases.APOE4 Genotype Exerts Greater Benefit in Lowering Plasma Cholesterol and Apolipoprotein B than Wild Type (E3/E3), after Replacement of Dietary Saturated Fats with Low Glycaemic Index Carbohydrates Absolute 10-year risk of dementia by age, sex and genotype: a population-based cohort study Are the effects ofAPOEϵ4 on cognitive function in nonclinical populations age- and gender-dependent?

P2860

Q28076438-F485DB4F-E82F-456E-8BEE-44214C13B832 Q28077212-8EC5B402-D470-4B26-A60C-C877CD709514 Q28087689-03821746-ACBB-46E0-9A92-41154549CD34 Q30239836-DD7404CF-5E6B-43FC-81BA-310B16B591F8 Q33858831-A77DB1D3-6DD9-49F4-A3E0-12291C559A0B Q33933106-4EB8CC0F-833D-4554-A0C7-8DB78419B222 Q34116095-60FAB5A5-F962-4B0E-8EED-46064543909C Q34411741-5D80A7B5-A4B7-4134-9F6B-E36BE8746948 Q35109507-0873A0B2-D607-492E-A639-2A8187CD647C Q35154972-DD476641-38C9-4201-B0F7-A28518180F6A Q35803446-3B9CCCA6-1F57-4490-8672-34A366427B60 Q35904756-51290910-5AED-4C6A-BFC4-7398CC34A30B Q36028401-D7E2D18B-179F-450D-92BF-DB2FCC6A64BE Q36032013-0987B9AF-6CC5-4E4C-92F3-389857DEE696 Q36472330-5D3465C3-AABF-457B-AE78-C25C2A92AED9 Q36617485-6FA7E66D-EE8C-42B0-AC1C-F6230EC99605 Q36873936-8FD828AC-4A76-4EAB-AD1B-D21B7BAD75EA Q36899589-BE1870BD-510A-4E66-93CE-F6175E7F02F8 Q37401173-1EA744AF-2684-4CE8-BD20-DC5EC86A3745 Q38230137-95E6D588-9F4E-40A1-90C3-F3C9F8DC9FEF Q38663579-88F00733-AF6E-4494-A389-9CF24566745D Q38763038-6DA6A699-48BE-456D-90AB-67A6705D09D2 Q38784011-07D5E8FB-8C8E-4F09-9384-9A4C6A749748 Q42704131-1E400CD7-2720-4879-B4AB-4B1915AE0232 Q46535385-C3DBA902-2538-41D7-92EE-BB81321A1A21 Q48873908-38035FCF-E080-499D-BB2C-8394F26BD3EF Q52879007-EEACD91A-6476-4AF7-9202-46E2F62064CB Q55260837-412D8CE6-E07F-43EF-98AB-6DF8FF682F94 Q58547737-C5F84332-A5A0-4301-B8AE-DD4D544A06AC Q58764367-36002CB9-18BE-4640-921A-C87ADEAA28EF Q59050338-F35FDF65-04A5-47B3-B33D-6683C6FF0D06

P2860

Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals.

Item

http://www.wikidata.org/entity/Q30414047

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu